Skip to main content
Equibles
TLRY logo

TLRY · Tilray Brands, Inc. · Metrics

Track TLRY — free

Use TLRY with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research TLRY.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$3.05 +0.02 (+0.59%)
Rebalance outlook locked
Market Cap
$412.70M
Shares
136.20M
Volume · Oct 20 2.9M Avg daily vol (3M) 4.21M

TLRY metrics

79 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$3.03
Market cap
$412.70M

Price action

20 metrics
Price change (1W)
-7.3%
Price change (30D)
-25.7%
Price change (3M)
-28.5%
Price change (6M)
-56.0%
Price change (YTD)
-66.4%
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
80.6%
Annualized volatility (3M)
50.8%
Beta
1.4
RSI (14D)
24.6
Price vs SMA 50
-26.0%
Price vs SMA 200
-47.2%
Avg volume (3M)
4.21M
Relative volume
0.7
Average dollar volume
$17.38M

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
136.20M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
0.3×
reciprocal yield 299.6%
EV / EBITDA
—
EV / EBIT
—
P / sales
0.4×
reciprocal yield 233.4%
P / book
0.3
reciprocal yield 393.4%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-39.8%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
3.2×
reciprocal yield 31.7%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-10-08

Profitability

9 metrics
Gross margin
29.1%
Operating margin
-9.3%
Trailing 12 months
Net margin
-17.1%
Gross profit (TTM)
$280.48M
Operating profit (TTM)
−$89.17M
Net income (TTM)
−$164.22M
Trailing 12 months
Diluted EPS (TTM)
$-1.41
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$8.12
Gross profit per diluted share (TTM)
$2.36
Operating profit per diluted share (TTM)
$-0.76
EBITDA per diluted share (TTM)
$-7.92
Net income per diluted share (TTM)
$-1.39
Operating cash flow per diluted share (TTM)
$-0.71
Free cash flow per diluted share (TTM)
$-1.45
Capital expenditures per diluted share (TTM)
$0.37
R&D per diluted share (TTM)
$0.00
Stock compensation per diluted share (TTM)
$0.41
Book value per share
$11.20

Growth

11 metrics
Revenue growth YoY
+22.7%
Year over year
Net income growth YoY
—
Revenue (TTM)
$963.10M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+25.8%
Year over year · more shares
Revenue CAGR (3Y)
+13.4%
Revenue CAGR (5Y)
+12.3%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-10.1%
Return on assets
-7.1%
Debt / equity
0.1
Current ratio
1.9
EBITDA (TTM)
−$412.88M
Free cash flow (TTM)
—
Quick ratio
1.1
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$91.27M
Latest balance sheet
Cash & equivalents
$214.96M
Total assets
$2.33B
Total debt
$126.73M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$84.34M
Capital expenditures (TTM)
$32.92M
R&D (TTM)
$409,000
SG&A (TTM)
—
Stock compensation (TTM)
$47.47M
R&D / revenue
0.0%
Stock compensation / revenue
4.9%

Ownership (13F)

9 metrics
13F filers
240
13F filer change QoQ
+24
Institutional ownership
18.1%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
4.3%
Private-fund adviser ownership
2.5%
Active holders' share change QoQ
+36.5%
Holder tenure
14.6
Price vs estimated holder cost
-54.2%

Ownership (registered funds)

1 metrics
Index-fund ownership
2.4%

Short interest

3 metrics
Short interest
13.8%
Latest settlement · 5.2 days to cover
Days to cover
5.2d
Short-squeeze score
64 / 100

Insider activity

2 metrics
Net insider buying (90D)
$69,225
Insider-sentiment score
84 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1731348 CUSIP 88688T209 13F (30d) 30 filings 30 filers Visit website Investor relations